Labcorp’s pathologists will use the software to review, interpret and manage digital images of slides for primary diagnosis.
Epredia, a global leader in precision cancer diagnostics and a subsidiary of PHC Holdings Corporation (TSE: 6523), and Mindpeak, a leading provider of artificial intelligence (AI) solutions for ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded ...
Voicebrook integration into Lumea's pathology software enables practical, voice-enabled workflows across the modern ...
Epredia will add Mindpeak AI modules for pathology to its digital pathology portfolio, offering enhanced precision and speed in diagnostic image review Epredia, a global leader in precision cancer ...
COVID-19 highlighted the lack of interoperability in our health systems. Here's how ETL (Extract, Transform, Load) networks ...
Lumea’s Viewer+™ software is now CE marked under IVDR for clinical use across Europe, making Lumea the most versatile ...
Tempus AI (NasdaqGS:TEM) has launched a new AI-driven HRD-RNA algorithm aimed at improving cancer diagnostics. The company has entered a partnership with Median Technologies to bring advanced lung ...
Bionano Symposium 2026 continues with Day 2: New Frontiers in Oncology and Bioprocessing Applications on February 24, 2026, from 7:00-10:00 AM PT. Attendees may also explore scientific posters ...
In 2026, MedTech players' success will hinge on their ability to balance near-term pressure with long-term transformation.
The precision cancer diagnostics firm Epredia will distribute Mindpeak's AI-based image recognition solutions for clinical diagnostics, research, and pharma development.
Dealbreaker on MSN
Danaher drops $10B to snatch Masimo in diagnostics push
The move reflects a broader industry shift toward consolidation and integrated care, as large healthcare companies seek scale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results